Valuation: iSpecimen Inc.

Market Cap 2.08M 1.86M 1.71M 1.55M 2.9M 197M 2.96M 20.43M 8.2M 104M 7.8M 7.64M 327M P/E 2024
-0.15x
P/E 2025 -0.11x
Enterprise Value -4.53M -4.06M -3.73M -3.38M -6.32M -430M -6.44M -44.53M -17.88M -226M -17.01M -16.65M -714M EV / Sales 2024
0.11x
EV / Sales 2025 -2.11x
Free-Float
100%
Yield 2024 *
-
Yield 2025 -
1 day+4.19%
1 week+1.04%
Current month-30.04%
1 month-30.04%
3 months-54.89%
6 months-84.22%
Current year-92.07%
1 week 0.75
Extreme 0.753
0.94
1 month 0.75
Extreme 0.753
1.15
Current year 0.75
Extreme 0.753
18
1 year 0.75
Extreme 0.753
32.96
3 years 0.75
Extreme 0.753
584
5 years 0.75
Extreme 0.753
23,183.92
10 years 0.75
Extreme 0.753
23,183.92
Manager TitleAgeSince
Chief Executive Officer 39 26/08/2026
Director of Finance/CFO 36 13/12/2024
Chief Executive Officer 32 07/11/2025
Director TitleAgeSince
Director/Board Member 31 25/09/2024
Director/Board Member 41 20/06/2025
Director/Board Member 35 07/11/2025
Date Insider Type Main position Quantity % Market Cap. Importance
25/9/24 Free

Chief Executive Officer

168 0.0013%
25/9/24 Free

Chairman

168 0.0013%
25/9/24 Free

Director

168 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+4.19%+1.04%-97.34%-99.84% 2.08M
-1.55%-0.50%-0.73%+54.73% 3,876B
-6.27%-6.42%-5.37%+1,153.30% 442B
-6.37%+3.57%-49.13%+28.55% 396B
-3.86%-3.86%+67.62%+206.74% 300B
+1.12%-1.47%-6.46%+68.19% 272B
-4.10%-2.77%+85.96%+473.69% 257B
-4.15%-33.87%-43.77%-7.55% 109B
-2.17%-24.40%+61.62%+141.62% 99.98B
+0.85%-5.15%-26.24%-52.51% 97.39B
Average -0.23%-7.38%-1.38%+196.69% 584.96B
Weighted average by Cap. +0.21%-2.10%+2.52%+161.40%

Financials

2024 2025
Net sales 9.29M 8.32M 7.65M 6.94M 12.96M 882M 13.21M 91.28M 36.64M 464M 34.87M 34.13M 1.46B 1.93M 1.73M 1.59M 1.44M 2.69M 183M 2.74M 18.95M 7.61M 96.35M 7.24M 7.09M 304M
Net income -12.5M -11.19M -10.3M -9.33M -17.44M -1.19B -17.76M -123M -49.29M -624M -46.9M -45.91M -1.97B -10.49M -9.39M -8.64M -7.83M -14.63M -996M -14.91M -103M -41.36M -524M -39.36M -38.52M -1.65B
Net Debt -1.57M -1.4M -1.29M -1.17M -2.19M -149M -2.23M -15.39M -6.18M -78.23M -5.88M -5.75M -247M -6.61M -5.92M -5.45M -4.94M -9.23M -628M -9.4M -64.96M -26.08M -330M -24.81M -24.29M -1.04B
Projected Income Statement - Annual - iSpecimen Inc.
Logo iSpecimen Inc.
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Employees
7
Date Price Change Volume
30/10/26 USD 0.8255 +4.19% 543,341
29/10/26 USD 0.7923 -9.35% 2,593,803
28/10/26 USD 0.8740 +0.22% 30,648
27/10/26 USD 0.8721 +3.85% 49,117
26/10/26 USD 0.8398 +2.79% 66,415

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - iSpecimen Inc.
  1. Stock Market
  2. Stocks
  3. ISPC Stock